Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ADRB1 variants in atrial fibrillation: small steps and giant leaps toward personalized therapy in cardiovascular disease.

Literature DB >> 22192669

ADRB1 variants in atrial fibrillation: small steps and giant leaps toward personalized therapy in cardiovascular disease.

Sharon Cresci.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2012 PMID： 22192669 PMCID： PMC3678958 DOI： 10.1016/j.jacc.2011.09.041

Source DB: PubMed Journal: J Am Coll Cardiol ISSN： 0735-1097 Impact factor: 24.094

Keyword Cloud
References

× No keyword cloud information.

21 in total

1. A comparison of rate control and rhythm control in patients with atrial fibrillation.

Authors: D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley
Journal: N Engl J Med Date: 2002-12-05 Impact factor: 91.245

Review 2. Adherence to long-term therapies management: a call for cardiovascular nursing managers and policymakers.

Authors: Eduardo Sabaté; Sabina De Geest
Journal: Prog Cardiovasc Nurs Date: 2004

3. The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity.

Authors: Heike Bruck; Kirsten Leineweber; Thomas Temme; Melanie Weber; Gerd Heusch; Thomas Philipp; Otto-Erich Brodde
Journal: J Am Coll Cardiol Date: 2005-11-04 Impact factor: 24.094

4. Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy.

Authors: Steven G Terra; Karen K Hamilton; Daniel F Pauly; Craig R Lee; J Herbert Patterson; Kirkwood F Adams; Richard S Schofield; Bernadette S Belgado; James A Hill; Juan M Aranda; Hossein N Yarandi; Julie A Johnson
Journal: Pharmacogenet Genomics Date: 2005-04 Impact factor: 2.089

5. A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure.

Authors: Stephen B Liggett; Jeanne Mialet-Perez; Surai Thaneemit-Chen; Stewart A Weber; Scott M Greene; Danielle Hodne; Bradley Nelson; Jennifer Morrison; Michael J Domanski; Lynne E Wagoner; William T Abraham; Jeffrey L Anderson; John F Carlquist; Heidi J Krause-Steinrauf; Laura C Lazzeroni; J David Port; Philip W Lavori; Michael R Bristow
Journal: Proc Natl Acad Sci U S A Date: 2006-07-14 Impact factor: 11.205

ADRB1 variants in atrial fibrillation: small steps and giant leaps toward personalized therapy in cardiovascular disease.

1. A comparison of rate control and rhythm control in patients with atrial fibrillation.

Review 2. Adherence to long-term therapies management: a call for cardiovascular nursing managers and policymakers.

3. The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity.

4. Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy.

5. A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure.

6. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.

7. Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure.

8. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.

9. Cost of care distribution in atrial fibrillation patients: the COCAF study.

10. Managing medication and compliance: physician--pharmacist--patient interactions.